Neurological Symptoms & Treatment Response
Longitudinal symptoms, episode diaries, medication patterns and daily function for neurological conditions.
Define the corpus
Define a neurological cohort around symptom trajectories, reported episodes and treatment experience. Specify the condition, event definitions and observation period needed to assess within-person changes over time.
Fields to assess
- Symptom severity and patient-reported episodes
- Medication use, changes and reported adherence
- Sleep, activity and daily functioning
- Eligible clinical-record and wearable context
Field-level coverage, missingness and provenance are confirmed during feasibility review. Listed modalities are not a promise of availability.
Project applications
- Neurological natural-history research
- Reported event patterns
- Treatment-response hypotheses
- Longitudinal model evaluation
Data interpretation
Diary entries are not automatically adjudicated clinical events. Diagnosis confirmation, episode definitions and follow-up completeness are assessed before a data specification is agreed.
Cohort and delivery specification
Request the condition definition, unique participant count, geography, observation period, follow-up distribution, field coverage and update schedule. The specification distinguishes self-reported observations, device measurements and clinical-record-derived fields.
Clinical coding, measurement units, data dictionaries, missingness and de-identification are reviewed for the proposed delivery. Clinical images and reports are assessed separately from original DICOM studies; genetic test summaries are assessed separately from raw variants, sequencing and omics matrices.
Licensing and due diligence
Annual licenses, defined-project access and refreshes can be discussed after feasibility review. Research, AI evaluation, model training, derivative models, sublicensing and exclusivity require specific written permissions. Patient recontact is not included in an inquiry or implied by a data license.
Source provenance, the legal supplier or controller and its authority to license are disclosed during buyer due diligence. These profiles may draw on overlapping populations; counts are not added across products.
Tell us the cohort you need.
Include conditions, required fields, follow-up and intended use. No patient records are needed to make an inquiry.